Vestas Wind Systems Shares Slide After Company Flags Margins at Low End of Guidance Snowflake to Acquire Natoma to Strengthen AI Agent Governance Capabilities AEM Hall of Fame Honors 75 Industry Pioneers Shaping Equipment Manufacturing Trump Trade Czar Signals Tariffs on Canada Mexico Will Stay Despite USMCA Fairholme Trims Stake in St Joe Company but the Investment Thesis Remains Intact RubioModi Talks Signal Potential Shifts in USIndia Trade and Energy Cooperation NMRK Q1 2026 Earnings EPS Surpasses Estimates by 18 Stock Unchanged RNXT Q1 2026 Earnings EPS Misses Estimates as Company Advances Pipeline Ingles Markets Q1 2026 Earnings EPS of 128 Supports Stock Gain Amid Limited Disclosure Voyager Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response Caleres Q1 2026 Earnings EPS Surprises to the Upside Despite Loss Shares Rally GTEC Q4 2025 Earnings EPS Misses Estimates Significantly Stock Surges 2091 SC II Acquisition Corp Units SCIIU Holds Steady at 1018 as SPAC Investors Await Catalyst Tempus AI Inc TEM Modestly Higher as It Holds Near Key Support QVC Group Inc QVCGA Holds Steady at 034 Amid Low Volatility TAVIR Rights Hold Flat at 015 Amid Low Volume and Eventual Catalyst Uncertainty Skyline Builders Group Holding Limited SKBL Struggles Near Support as Selling Pressure Intensifies Government Readies Major Overhaul of Tax Administration to Ensure Smooth India GST Rollout EWCZ Q4 2025 Earnings Strong Earnings Beat as Cost Discipline Drives Profitability Surprise GSK Shares Hold Steady Near 51 as Market Awaits Catalysts ADIL Q1 2026 Earnings Narrower Loss Surprises on Lower Expenses WRLD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Rallies FRPT Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Valley National Bancorp VLY Q1 2026 Earnings EPS Beats Estimates as Loan Growth Holds Steady PKE Q1 2026 Earnings EPS of 015 Reported Amidst Quiet Quarter SPMC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline